What it is
Skin substitutes is a broad term for products placed on a wound to cover it and support the healing environment. Some are made from human tissue, such as donated amniotic membrane. Others come from animal sources or are made synthetically.
These products are not all the same. They differ in what they are made of, how they are regulated, and what they are meant to be used for. Some are regulated as medical devices, some as biologic products, and some are handled under other rules, so the FDA status can vary from product to product.
Medicare skin substitute coverage refers to whether and how Medicare helps pay for these products and the visits where they are used. Coverage rules can be detailed and can change over time. They often depend on the product, the type of wound, the setting of care, and the documentation a provider keeps.
How it’s traditionally been approached
Wound care has traditionally started with the basics: looking at why a wound is not healing, checking blood flow and swelling, relieving pressure, keeping the area clean, and using dressings suited to the wound. Skin substitutes have generally been considered in specific situations, not as a first step for every wound.
Medicare generally has its own requirements for when it may pay for wound-related products. These can include things like the type of wound, how long it has been present, and whether other standard care has been tried. Regional Medicare contractors may publish their own policies, and those policies can be updated.
Amniotic membrane used as a wound covering is an established use. Injectable amniotic, umbilical cord, Wharton's jelly and exosome products for joints, pain, hair or skin rejuvenation are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Coverage for products without approval for a given use is often limited or unavailable, so it is worth asking directly.
How the right doctor may help
The right provider, such as a wound care specialist or a podiatrist, may help you understand whether a skin substitute is something to consider for your situation at all. A visit usually begins with a review of your health history, a look at the wound, and a discussion of what has been tried so far. A licensed clinician decides what is appropriate only after an evaluation.
A provider's office may also help explain how Medicare rules relate to your care, and what documentation is typically needed. Many offices have staff who can check benefits, though the final decision on payment rests with Medicare and your plan. A provider cannot promise that a product will be covered or that a wound will heal.
Questions you might bring: Is this product FDA-cleared, approved, or regulated in another way, and for what use? What is its tissue source? What are the risks and the alternatives? What is the total cost to me, including visits and any amount I may owe? Has coverage been checked with Medicare or my plan before treatment begins?
The whole-person view
Living with a wound that is slow to heal can affect the whole person. Pain, poor sleep, limited movement, and worry can all influence each other, and stress can make everyday routines harder to manage. Paying attention to rest, nutrition, movement your provider says is appropriate, and emotional well-being is part of a whole-person view.
Some people find that body-based support, such as the approaches offered through Somatic Experiences, helps them feel more at ease in their bodies during a long recovery. Others value talking through the stress of ongoing care and insurance questions with a counselor, such as those found through Therapists.plus. These are options to explore, not replacements for medical care.
Somatic Experiences: nervous system regulation →Somatic Experiences: embodiment and movement →Therapists.plus: mind body connection →
Keep in mind
- Only a licensed clinician can decide whether a skin substitute is appropriate, after an evaluation; this page does not diagnose or recommend treatment.
- Medicare rules and product regulations can change, so confirm current coverage with Medicare, your plan, and your provider before treatment, and never assume a product is covered.
- Injectable amniotic or umbilical cord products for pain, joints or cosmetic uses are generally not FDA-approved for those uses, and most contain no living stem cells after processing.
- Wounds that show signs of infection, spreading redness, fever, or severe pain need prompt professional care; for emergencies call 911, and in a crisis call or text 988.
Not sure where to start? Answer a few gentle questions and choose who you’d like to hear from.
Frequently asked questions
Does Medicare cover skin substitutes?
Sometimes, but it depends on the specific product, the type of wound, the care setting, and Medicare's current rules. Coverage is not automatic, and it is not the same for every product. Ask your provider's office to check coverage with Medicare or your plan before treatment.
What is Medicare skin substitute coverage generally based on?
It is generally based on factors such as the product's regulatory status, the kind of wound, and whether standard wound care has already been tried. Documentation from your provider usually plays a role as well. Specific requirements can vary by region and change over time.
Are amniotic skin substitutes FDA-approved?
It depends on the product and the use. Amniotic membrane as a wound covering is an established use, but regulatory status differs from product to product. Injectable amniotic products for joints, pain or cosmetic uses are generally not FDA-approved for those purposes, so ask your provider about a product's FDA status.
Who can tell me if a skin substitute is right for my wound?
A licensed clinician, such as a wound care specialist or podiatrist, can decide after evaluating you. They can look at your wound, health history, and what has already been tried. No website can make that decision for you.
What should I ask before agreeing to a skin substitute?
Ask about the product's FDA status, its tissue source, the possible risks, the alternatives, and the total cost to you. Also ask whether coverage has been confirmed with Medicare or your plan before treatment. Getting answers in writing can be helpful.
Will Medicare pay for injectable amniotic products for joint pain?
Generally not, because these products are typically not FDA-approved for joint pain and the FDA has warned the public about unapproved regenerative products. Coverage is often unavailable for uses that are not approved. Ask your provider about the status, risks, alternatives, and total cost, and check with Medicare before treatment.
Educational resource. Amniotic Doctors shares general information and connects people with independent doctors. It is not medical advice, diagnosis or treatment. Talk with a licensed professional about your health.